English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Literature reveals that quercetin shows hypoglycaemic active by more than one way. In present work virtual docking study of quercetinand its probable analogs was carried out on insulin receptor PDB ID:1IR3by using biopredicta module of Vlife MDS 4.3.In results of virtual screening it was found that 2-(3, 4 dihydroxy phenyl)-3,5,7-trihydroxy-4H chromen-4one(quercetin) and its probable analogs 3-hydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one (analog 1), 3,7-dihydroxy-2-(3-methoxyphenyl)-4H-chromen-4-one(analog5)and 3-hydroxy-2(4-hydroxyphenyl)-7-methoxy-4H-chromen-4one(analog7) showed promising results and hence were synthesized. The results of invivo screening confirm the results of virtual screening as analogs 1, 5 and 7 have shown better activity hypoglycamic activity than quercetin.

Virtual Screening Based Synthesis of Analogs of Quercetin As Insulin Receptor Activators And In-Vivo Comparative Evaluation For Anti-Diabetic Activity